Compare Sonida Senior Living, Inc. with Similar Stocks
Stock DNA
Pharmaceuticals & Biotechnology
USD 600 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.44
-66.92%
7.41
Total Returns (Price + Dividend) 
Sonida Senior Living, Inc. for the last several years.
Risk Adjusted Returns v/s 
News

Sonida Senior Living Reaches New 52-Week High of $33.50
Sonida Senior Living, Inc. achieved a new 52-week high of USD 33.50 on November 17, 2025, significantly up from its low of USD 19.34. The company has outperformed the S&P 500 over the past year, despite being loss-making and exhibiting a unique financial structure.
Read full news article
Sonida Senior Living Hits New 52-Week High at $33.25
Sonida Senior Living, Inc. achieved a new 52-week high of USD 33.25 on November 10, 2025, reflecting a strong performance over the past year. The company, operating in the Pharmaceuticals & Biotechnology sector, has a market capitalization of USD 489 million and is currently loss-making with a negative return on equity.
Read full news article Announcements 
Corporate Actions 
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2025
Shareholding Compare (%holding) 
Foreign Institutions
Held in 14 Schemes (4.29%)
Held by 21 Foreign Institutions (6.48%)
Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ
QoQ Growth in quarter ended Sep 2025 is 4.81% vs 1.74% in Jun 2025
QoQ Growth in quarter ended Sep 2025 is -1,265.00% vs 84.62% in Jun 2025
Annual Results Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 19.19% vs 7.09% in Dec 2023
YoY Growth in year ended Dec 2024 is 84.36% vs 61.21% in Dec 2023






